Overview

Phase III Clinical Trial of TRAVATAN Z in Ocular Surface Health

Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to compare two ophthalmic solutions in patients with open-angle glaucoma or ocular hypertension.
Phase:
Phase 3
Details
Lead Sponsor:
Alcon Research
Treatments:
Latanoprost
Ophthalmic Solutions
Pharmaceutical Solutions
Travoprost